Impact of the 5-HT3 receptor channel system for insulin secretion and interaction of ginger extracts.
The relevance of serotonin and in particular that of 5-HT(3) receptors is unequivocal with respect to emetic/antiemetic effects, but it is controversial with respect to antidiabetic effects. The effects of tropisetron (5-HT(3) receptor antagonist) and various ginger (Zingiber officinale) extracts (known to interact with the 5-HT(3) receptor channel system) were investigated. Serotonin (32 to 500 microM) inhibits insulin release (RIA) from INS-1 cells which is reversed by tropisetron (10 to 100 microM) and two different ginger extracts (spissum and an oily extract). Their effects are obvious even in the absence of serotonin but are more pronounced in its presence (doubled to tripled). Specific 5-HT(3) binding sites are present in INS-1 cells using 0.4 nM [3H] GR65630 in displacement experiments. The in vitro data with respect to ginger are corroborated by in vivo data on glucose-loaded rats showing that blood glucose (Glucoquant) is decreased by approximately 35% and plasma insulin (RIA) is increased by approximately 10%. Both the spissum extract and the oily ginger extract are effective in two other models: they inhibit [(14)C] guanidinium uptake into N1E-115 cells (model of 5-HT(3) effects) and relax rat ileum both directly and as a serotonin antagonistic effect. Other receptors addressed by ginger are 5-HT(2) receptors as demonstrated by using methysergide and ketanserin. They weakly antagonize the serotonin effect as well. It may be concluded that serotonin and in particular the 5-HT(3) receptor channel system are involved in modulating insulin release and that tropisetron and various ginger extracts can be used to improve a diabetic situation.
Heimes
Katharina
K
Department of Pharmacology, Institute of Medicinal Chemistry, Westfälische Wilhelms-University of Münster, Hittorfstrasse 58-62, 48149 Münster, Germany.
Feistel
Björn
B
Verspohl
Eugen J
EJ
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002478:Cells, Cultured; D003920:Diabetes Mellitus / Q000188:drug therapy; D020939:Zingiber officinale / Q000737:chemistry*; D019791:Guanidine / Q000378:metabolism; D007211:Indoles / Q000494:pharmacology; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D050417:Insulin-Secreting Cells / Q000187:drug effects* / Q000378:metabolism; D007473:Ion Channels / Q000037:antagonists & inhibitors / Q000378:metabolism*; D007650:Ketanserin / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D010936:Plant Extracts / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D044406:Receptors, Serotonin, 5-HT3 / Q000378:metabolism*; D012701:Serotonin / Q000494:pharmacology; D058831:Serotonin 5-HT3 Receptor Antagonists; D012702:Serotonin Antagonists / Q000494:pharmacology*; D000077526:Tropisetron
D001786:Blood Glucose; D007211:Indoles; D007328:Insulin; D007473:Ion Channels; D010936:Plant Extracts; D044406:Receptors, Serotonin, 5-HT3; D058831:Serotonin 5-HT3 Receptor Antagonists; D012702:Serotonin Antagonists; D012701:Serotonin; D000077526:Tropisetron; D007650:Ketanserin; D019791:Guanidine; D008784:Methysergide